Cargando…
Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
Despite some success in secondary brain metastases, targeted or immune-based therapies have shown limited efficacy against primary brain malignancies such as glioblastoma (GBM). Although the intratumoral heterogeneity of GBM is implicated in treatment resistance, it remains unclear whether this dive...
Autores principales: | Schaettler, Maximilian O., Richters, Megan M., Wang, Anthony Z., Skidmore, Zachary L., Fisk, Bryan, Miller, Katherine E., Vickery, Tammi L., Kim, Albert H., Chicoine, Michael R., Osbun, Joshua W., Leuthardt, Eric C., Dowling, Joshua L., Zipfel, Gregory J., Dacey, Ralph G., Lu, Hsiang-Chih, Johanns, Tanner M., Griffith, Obi L., Mardis, Elaine R., Griffith, Malachi, Dunn, Gavin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296070/ https://www.ncbi.nlm.nih.gov/pubmed/34610950 http://dx.doi.org/10.1158/2159-8290.CD-21-0291 |
Ejemplares similares
-
OMIC-13. THE ROLE OF COPY NUMBER ALTERATIONS IN PREDICTING SURVIVAL AND INFLUENCING TREATMENT OF CHILDHOOD BRAIN TUMORS
por: Freshour, Sharon, et al.
Publicado: (2021) -
Best practices for bioinformatic characterization of neoantigens for clinical utility
por: Richters, Megan M., et al.
Publicado: (2019) -
Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021) -
Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design
por: Hundal, Jasreet, et al.
Publicado: (2017) -
Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer
por: Barnell, Erica K., et al.
Publicado: (2022)